Exenatide/insulin sublingual(Biolingus)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameExenatide/insulin sublingual(Biolingus)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsInsulin receptor agonistsOrnithine decarboxylase stimulants +[5] 
TargetsGlucagon-like peptide 1 receptorProtein-tyrosine kinasesInsulin receptor +[5] 
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolingus
China Registration ClassN/A

Develop Information

Active CompaniesBiolingus
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A